F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, [...]
Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study
The patients used tirzepatide, sold as Mounjaro or Zepbound, but [...]
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles makes it difficult for patients to [...]
Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth
The maker of Zepbound and Mounjaro launched a new platform [...]
Zepbound, el nuevo medicamento aprobado por la FDA para perder peso
Este fármaco tiene el mismo compuesto que Mounjaro, el muy [...]
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
Zepbound, which is already sold by Eli Lilly as the [...]
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.
The obesity medication contains tirzepatide, the same active ingredient in [...]
Los medicamentos cotra la obesidad tienen sobreprecio, pero esto puede cambiar
Un artículo reciente reveló que los precios netos de los [...]
How Much Do Ozempic and Wegovy Cost? Not What You Think.
Drug companies are making billions from a new class of [...]
Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side [...]